THC Reduced Brain Attention Responses, and CBD Didn't Reverse It in This Study
Pure THC significantly reduced P300 brain wave amplitude (a marker of attention), but a cannabis extract containing both THC and CBD failed to prevent this reduction, contrary to expectations.
Quick Facts
What This Study Found
In a double-blind crossover study, 20 healthy volunteers received pure THC, a standardized cannabis extract containing THC and CBD, or placebo on separate occasions.
As expected, pure THC significantly reduced P300 amplitude at frontal, central, and parietal electrodes. P300 is a brain wave that reflects attention and working memory capacity, and its reduction mirrors the pattern seen in schizophrenia.
Unexpectedly, the cannabis extract containing both THC and CBD also reduced P300 amplitude. CBD did not prevent or reverse THC's effect on this measure, contrary to the hypothesis that CBD counteracts THC's cognitive effects.
The authors speculated this could reflect an insufficient CBD dose or that the P300 is generated by neurotransmitter systems not influenced by CBD. No correlations were found between blood cannabinoid levels and P300 parameters.
Key Numbers
20 healthy volunteers (10 male, mean age 28.2). THC significantly reduced P300 amplitude at midline frontal, central, and parietal electrodes. Cannabis extract (THC+CBD) also reduced P300. No correlation between blood cannabinoid levels and P300.
How They Did This
Prospective, double-blind, placebo-controlled crossover study. 20 healthy volunteers received THC, standardized cannabis extract (THC+CBD), or placebo on separate occasions. P300 event-related potentials were recorded during a choice reaction task.
Why This Research Matters
While many studies suggest CBD counteracts THC, this study found one important measure where it did not. This complicates the narrative that CBD universally protects against THC's cognitive effects and suggests the interaction is task-specific and dose-dependent.
The Bigger Picture
This study provided a counterpoint to the earlier finding (RTHC-00279) that CBD enhanced mismatch negativity. Together, these studies suggest CBD's ability to modify THC effects depends on which brain measure is examined. P300 and MMN reflect different cognitive processes and neural generators.
What This Study Doesn't Tell Us
Relatively small sample (20 subjects). Only one dose ratio was tested. The CBD dose may have been insufficient. P300 is one specific measure that may not capture all cognitive effects.
Questions This Raises
- ?At what CBD:THC ratio would CBD protect P300 amplitude?
- ?Are there specific cognitive domains where CBD does not counteract THC?
- ?Does the P300 reduction have functional significance for attention in daily life?
Trust & Context
- Key Stat:
- CBD did not prevent THC's reduction of the P300 attention brain wave
- Evidence Grade:
- This is a well-designed double-blind crossover RCT, providing moderate evidence for this specific measure, though the small sample limits generalizability.
- Study Age:
- Published in 2008. Subsequent research has shown that CBD's ability to counteract THC varies by cognitive domain, dose, and timing.
- Original Title:
- Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
- Published In:
- European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 18(8), 569-77 (2008)
- Authors:
- Roser, Patrik(9), Juckel, Georg(5), Rentzsch, Johannes(3), Nadulski, Thomas, Gallinat, Jürgen, Stadelmann, Andreas M
- Database ID:
- RTHC-00328
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Doesn't CBD protect against THC's effects?
Some studies find CBD counteracts certain THC effects, but this study found one measure (P300 attention wave) where CBD did not help. The CBD-THC interaction appears to be more selective than previously thought.
What is the P300?
The P300 is a brain wave that occurs about 300ms after a stimulus requiring attention. Its amplitude reflects how much attentional resource the brain allocates. Reduced P300 is consistently found in schizophrenia and with acute THC.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- thc-and-antipsychotics-complicated-relationship
Cite This Study
https://rethinkthc.com/research/RTHC-00328APA
Roser, Patrik; Juckel, Georg; Rentzsch, Johannes; Nadulski, Thomas; Gallinat, Jürgen; Stadelmann, Andreas M. (2008). Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 18(8), 569-77. https://doi.org/10.1016/j.euroneuro.2008.04.008
MLA
Roser, Patrik, et al. "Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.." European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2008. https://doi.org/10.1016/j.euroneuro.2008.04.008
RethinkTHC
RethinkTHC Research Database. "Effects of acute oral Delta9-tetrahydrocannabinol and standa..." RTHC-00328. Retrieved from https://rethinkthc.com/research/roser-2008-effects-of-acute-oral
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.